Search

everythinglearnresearchcommunity

for

Search:↓

Mogamulizumab treatment in Sézary syndrome may cause skin issues and hair loss but can lead to a complete response.

Alopecia Areata is an autoimmune disease causing hair loss in patches, often starting before age 20, and while some cases recover on their own, treatments include topical corticosteroids, minoxidil, and promising new methods like IL-31 antibodies and 308-nm Excimer laser therapy.

A Gsdma3 mutation causes hair loss due to stem cell damage from skin inflammation.

A patient with leukemia/lymphoma also had multiple autoimmune diseases, suggesting a link between them.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Calprotectin levels are higher in alopecia areata patients, indicating systemic inflammation.

Targeting the AhR pathway may help treat alopecia areata.

Dissecting cellulitis of the scalp is a condition that causes inflammation and scarring on the scalp, mainly affecting African-American men, and can lead to permanent hair loss.

Anti-TNF therapy can cause a rare hair loss condition similar to alopecia areata.

About half of people with mild alopecia areata see hair regrowth in a year, but relapses are common.

Alopecia areata involves immune response and gene changes affecting hair loss.

Recognizing CVG can help diagnose systemic amyloidosis early.

A microneedle patch can help regrow hair by restoring immune balance in hair follicles.

Autoimmune reactions may cause both alopecia areata and HAM.

Alopecia areata can be triggered by specific immune cells without genetic or environmental factors.

Alopecia areata is an autoimmune condition causing patchy hair loss, with treatments focusing on immune system regulation and hair regrowth.

Dupilumab successfully treated a woman's alopecia areata and bullous pemphigoid, leading to full hair regrowth and symptom resolution.

A new mouse model helps understand and find treatments for alopecia areata.

A woman's shingles infection triggered her first episode of a rare neurological disorder and blood vessel inflammation.

Alopecia areata is linked to blood cancers, especially in older patients, but not to most solid cancers.

The paper concludes that the patchiness of alopecia areata is likely due to when the immune attack happens in the hair growth cycle.

Skin lymphoproliferative disorders are hard to diagnose and often linked to systemic diseases, but most have a good prognosis with accurate diagnosis.

Exclamation-mark hairs and yellow dots indicate alopecia areata, while follicular ostia loss and white scarring indicate lichen planopilaris and discoid lupus erythematosus.

New treatments for alopecia areata, like JAK inhibitors and immunomodulators, are promising.

Renal histology is crucial for diagnosing simultaneous SLE and IgG4RD.

Hair follicles prevent NK cell attacks to avoid hair loss.

Autoimmune conditions can be linked to trichoepitheliomas, with treatment focusing on cosmetic concerns.

Atypical male hair loss may not respond to usual treatments.